(Q43511728)

24 November 2017

title

Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake (English)

1 reference

24 November 2017

Effects of Intravenous Nesiritide on Human Coronary Vasomotor Regulation and Myocardial Oxygen Uptake (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Cardiology and cardiovascular medicine

1 January 2024

main subject

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

1 January 2024

author name string

Andrew Klein

2

1 reference

24 November 2017

Kanu Chatterjee

4

1 reference

24 November 2017

Andrew D. Michaels

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742984

1 January 2024

James A. Madden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742984

1 January 2024

language of work or name

English

0 references

publication date

12 May 2003

1 reference

full work available at URL

24 November 2017

https://www.ahajournals.org/doi/full/10.1161/01.CIR.0000070547.88378.EA

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

1 January 2024

1 reference

24 November 2017

volume

107

1 reference

24 November 2017

issue

21

1 reference

24 November 2017

page(s)

2697-2701

1 reference

Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects

24 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

1 January 2024

2

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group

1 January 2024

3

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

American Journal of Physiology

1 January 2024

4

276

H1935

1999

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Relaxant effect of human brain natriuretic peptide on human artery and vein tissue

1 January 2024

5

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.

1 January 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects.

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

American Journal of Physiology

1 January 2024

8

276

H1049

1999

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables.

1 January 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Comparison of different quantitative coronary analysis systems: ARTREK, CAAS, and CMS.

1 January 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Integrative physiology of coronary microcirculation

1 January 2024

16

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Coronary microcirculation: physiology and pharmacology

1 January 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Participation of adenosine 5'-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor

1 January 2024

18

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Suppression of hyperventilation-induced attacks with infusion of B-type (brain) natriuretic peptide in patients with variant angina

1 January 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

1 January 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain

1 January 2024

21

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure

1 January 2024

22

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

Validation of Doppler FloWire for measurement of coronary flow reserve in humans

1 January 2024

24

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070547.88378.EA

1 January 2024

Identifiers

1 reference

24 November 2017

1 reference